These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 10727653)
1. Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes. Deschênes I; Baroudi G; Berthet M; Barde I; Chalvidan T; Denjoy I; Guicheney P; Chahine M Cardiovasc Res; 2000 Apr; 46(1):55-65. PubMed ID: 10727653 [TBL] [Abstract][Full Text] [Related]
2. Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome. Rook MB; Bezzina Alshinawi C; Groenewegen WA; van Gelder IC; van Ginneken AC; Jongsma HJ; Mannens MM; Wilde AA Cardiovasc Res; 1999 Dec; 44(3):507-17. PubMed ID: 10690282 [TBL] [Abstract][Full Text] [Related]
3. Nav1.5/R1193Q polymorphism is associated with both long QT and Brugada syndromes. Huang H; Zhao J; Barrane FZ; Champagne J; Chahine M Can J Cardiol; 2006 Mar; 22(4):309-13. PubMed ID: 16568155 [TBL] [Abstract][Full Text] [Related]
4. Biophysical phenotypes of SCN5A mutations causing long QT and Brugada syndromes. Baroudi G; Chahine M FEBS Lett; 2000 Dec; 487(2):224-8. PubMed ID: 11150514 [TBL] [Abstract][Full Text] [Related]
5. Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children. Antzelevitch C J Electrocardiol; 2001; 34 Suppl():177-81. PubMed ID: 11781953 [TBL] [Abstract][Full Text] [Related]
6. Brugada and long QT-3 syndromes: two phenotypes of the sodium channel disease. Khan IA; Nair CK Ann Noninvasive Electrocardiol; 2004 Jul; 9(3):280-9. PubMed ID: 15245345 [TBL] [Abstract][Full Text] [Related]
8. Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect. Veltmann C; Barajas-Martinez H; Wolpert C; Borggrefe M; Schimpf R; Pfeiffer R; Cáceres G; Burashnikov E; Antzelevitch C; Hu D J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381756 [TBL] [Abstract][Full Text] [Related]
9. Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channel. Wei J; Wang DW; Alings M; Fish F; Wathen M; Roden DM; George AL Circulation; 1999 Jun; 99(24):3165-71. PubMed ID: 10377081 [TBL] [Abstract][Full Text] [Related]
10. Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome. Baroudi G; Napolitano C; Priori SG; Del Bufalo A; Chahine M Can J Cardiol; 2004 Mar; 20(4):425-30. PubMed ID: 15057319 [TBL] [Abstract][Full Text] [Related]
11. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome. Antzelevitch C; Yan GX; Shimizu W J Electrocardiol; 1999; 32 Suppl():158-65. PubMed ID: 10688320 [TBL] [Abstract][Full Text] [Related]
12. Enhanced Na(+) channel intermediate inactivation in Brugada syndrome. Wang DW; Makita N; Kitabatake A; Balser JR; George AL Circ Res; 2000 Oct; 87(8):E37-43. PubMed ID: 11029409 [TBL] [Abstract][Full Text] [Related]
13. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Ackerman MJ; Splawski I; Makielski JC; Tester DJ; Will ML; Timothy KW; Keating MT; Jones G; Chadha M; Burrow CR; Stephens JC; Xu C; Judson R; Curran ME Heart Rhythm; 2004 Nov; 1(5):600-7. PubMed ID: 15851227 [TBL] [Abstract][Full Text] [Related]
14. Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death. Rossenbacker T; Carroll SJ; Liu H; Kuipéri C; de Ravel TJ; Devriendt K; Carmeliet P; Kass RS; Heidbüchel H Heart Rhythm; 2004 Nov; 1(5):610-5. PubMed ID: 15851228 [TBL] [Abstract][Full Text] [Related]
15. De novo mutation in the SCN5A gene associated with early onset of sudden infant death. Wedekind H; Smits JP; Schulze-Bahr E; Arnold R; Veldkamp MW; Bajanowski T; Borggrefe M; Brinkmann B; Warnecke I; Funke H; Bhuiyan ZA; Wilde AA; Breithardt G; Haverkamp W Circulation; 2001 Sep; 104(10):1158-64. PubMed ID: 11535573 [TBL] [Abstract][Full Text] [Related]
16. A missense mutation in the sodium channel β1b subunit reveals SCN1B as a susceptibility gene underlying long QT syndrome. Riuró H; Campuzano O; Arbelo E; Iglesias A; Batlle M; Pérez-Villa F; Brugada J; Pérez GJ; Scornik FS; Brugada R Heart Rhythm; 2014 Jul; 11(7):1202-9. PubMed ID: 24662403 [TBL] [Abstract][Full Text] [Related]
17. Novel mechanism for Brugada syndrome: defective surface localization of an SCN5A mutant (R1432G). Baroudi G; Pouliot V; Denjoy I; Guicheney P; Shrier A; Chahine M Circ Res; 2001 Jun; 88(12):E78-83. PubMed ID: 11420310 [TBL] [Abstract][Full Text] [Related]
18. Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation. Makita N; Horie M; Nakamura T; Ai T; Sasaki K; Yokoi H; Sakurai M; Sakuma I; Otani H; Sawa H; Kitabatake A Circulation; 2002 Sep; 106(10):1269-74. PubMed ID: 12208804 [TBL] [Abstract][Full Text] [Related]
19. A novel mutation in SCN5A, delQKP 1507-1509, causing long QT syndrome: role of Q1507 residue in sodium channel inactivation. Keller DI; Acharfi S; Delacrétaz E; Benammar N; Rotter M; Pfammatter JP; Fressart V; Guicheney P; Chahine M J Mol Cell Cardiol; 2003 Dec; 35(12):1513-21. PubMed ID: 14654377 [TBL] [Abstract][Full Text] [Related]
20. Clinical and molecular heterogeneity in the Brugada syndrome: a novel gene locus on chromosome 3. Weiss R; Barmada MM; Nguyen T; Seibel JS; Cavlovich D; Kornblit CA; Angelilli A; Villanueva F; McNamara DM; London B Circulation; 2002 Feb; 105(6):707-13. PubMed ID: 11839626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]